A letter to the editor is presented in response to the articles "Screening and prostate-cancer mortality in a randomized European study," by F.H. Schoder, J. Hugosson, M.J. Roobol, T.L. Tammela, S. Ciatto and V. Nelen and "Mortality results from a randomized prostate-cancer screening trial," by G.L. Andriole, E.D. Crawford and R.L. Grubb.